Hantz Financial Services, Inc. Roivant Sciences Ltd. Transaction History
Hantz Financial Services, Inc.
- $5.74 Billion
- Q4 2024
A detailed history of Hantz Financial Services, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 603 shares of ROIV stock, worth $6,283. This represents 0.0% of its overall portfolio holdings.
Number of Shares
603
Previous 603
-0.0%
Holding current value
$6,283
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
328Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$686 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$647 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$498 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$459 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$369 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.34B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...